Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.55636751 |
2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.13191422 |
3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.13191422 |
4 | growth hormone receptor signaling pathway (GO:0060396) | 5.67057102 |
5 | regulation of RIG-I signaling pathway (GO:0039535) | 5.46549816 |
6 | myeloid dendritic cell differentiation (GO:0043011) | 5.28730143 |
7 | natural killer cell mediated immunity (GO:0002228) | 5.16591282 |
8 | natural killer cell mediated cytotoxicity (GO:0042267) | 5.16591282 |
9 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 5.01450503 |
10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.97864964 |
11 | cellular response to growth hormone stimulus (GO:0071378) | 4.92614078 |
12 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.90134380 |
13 | myeloid dendritic cell activation (GO:0001773) | 4.82168520 |
14 | regulation of necroptotic process (GO:0060544) | 4.79876401 |
15 | negative regulation of necroptotic process (GO:0060546) | 4.68770104 |
16 | T-helper cell differentiation (GO:0042093) | 4.63048244 |
17 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 4.63048244 |
18 | necroptotic process (GO:0070266) | 4.62300498 |
19 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 4.61638704 |
20 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.59271158 |
21 | negative thymic T cell selection (GO:0045060) | 4.49622476 |
22 | response to muramyl dipeptide (GO:0032495) | 4.44882511 |
23 | neutrophil activation involved in immune response (GO:0002283) | 4.44682468 |
24 | dendritic cell differentiation (GO:0097028) | 4.41437177 |
25 | interferon-gamma secretion (GO:0072643) | 4.40807265 |
26 | neutrophil activation (GO:0042119) | 4.37923794 |
27 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.23587549 |
28 | negative regulation of fibrinolysis (GO:0051918) | 4.22775939 |
29 | positive regulation of antigen processing and presentation (GO:0002579) | 4.17646261 |
30 | negative T cell selection (GO:0043383) | 4.17218994 |
31 | regulation of T cell tolerance induction (GO:0002664) | 4.11387980 |
32 | granulocyte activation (GO:0036230) | 4.07192480 |
33 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.06971769 |
34 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.00414474 |
35 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.99197232 |
36 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.99197232 |
37 | T cell differentiation involved in immune response (GO:0002292) | 3.99197232 |
38 | regulation of hypersensitivity (GO:0002883) | 3.96612461 |
39 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.85737696 |
40 | positive regulation of T cell cytokine production (GO:0002726) | 3.79038626 |
41 | mature B cell differentiation (GO:0002335) | 3.71384621 |
42 | regulation of antigen processing and presentation (GO:0002577) | 3.71266575 |
43 | positive regulation of interleukin-2 production (GO:0032743) | 3.69430584 |
44 | embryonic process involved in female pregnancy (GO:0060136) | 3.67491793 |
45 | positive regulation of interleukin-12 production (GO:0032735) | 3.67445418 |
46 | plasma lipoprotein particle assembly (GO:0034377) | 3.65477997 |
47 | negative regulation of necrotic cell death (GO:0060547) | 3.57387193 |
48 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.57351622 |
49 | pinocytosis (GO:0006907) | 3.56475740 |
50 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.49097568 |
51 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.44756066 |
52 | programmed necrotic cell death (GO:0097300) | 3.43615943 |
53 | positive regulation of B cell differentiation (GO:0045579) | 3.40285850 |
54 | positive regulation of protein oligomerization (GO:0032461) | 3.39456223 |
55 | regulation of apoptotic cell clearance (GO:2000425) | 3.39057924 |
56 | cellular response to zinc ion (GO:0071294) | 3.37776012 |
57 | regulation of protein activation cascade (GO:2000257) | 3.37541223 |
58 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.35408399 |
59 | T cell migration (GO:0072678) | 3.34844159 |
60 | regulation of complement activation (GO:0030449) | 3.31968464 |
61 | lymphocyte migration (GO:0072676) | 3.31619106 |
62 | necrotic cell death (GO:0070265) | 3.31434158 |
63 | regulation of fibrinolysis (GO:0051917) | 3.31272055 |
64 | protein-lipid complex assembly (GO:0065005) | 3.31110741 |
65 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.27564084 |
66 | response to prostaglandin E (GO:0034695) | 3.25702147 |
67 | leukocyte mediated cytotoxicity (GO:0001909) | 3.24993772 |
68 | regulation of tolerance induction (GO:0002643) | 3.24810737 |
69 | positive regulation of humoral immune response (GO:0002922) | 3.23478966 |
70 | regulation of necrotic cell death (GO:0010939) | 3.22427582 |
71 | T cell activation involved in immune response (GO:0002286) | 3.22404543 |
72 | regulation of B cell differentiation (GO:0045577) | 3.16219723 |
73 | hypotonic response (GO:0006971) | 3.16015492 |
74 | regulation of natural killer cell differentiation (GO:0032823) | 3.13562257 |
75 | hepatocyte apoptotic process (GO:0097284) | 3.13334183 |
76 | thymic T cell selection (GO:0045061) | 3.12094070 |
77 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.10060504 |
78 | positive regulation of natural killer cell activation (GO:0032816) | 3.04317300 |
79 | regulation of interleukin-12 production (GO:0032655) | 3.03313184 |
80 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.02919068 |
81 | positive regulation of extracellular matrix organization (GO:1903055) | 3.02329787 |
82 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.01901246 |
83 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.00484897 |
84 | T-helper 1 type immune response (GO:0042088) | 3.00301630 |
85 | protein carboxylation (GO:0018214) | 3.00092051 |
86 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.00092051 |
87 | regulation of response to interferon-gamma (GO:0060330) | 2.98839923 |
88 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.97724363 |
89 | positive regulation of blood coagulation (GO:0030194) | 2.97249333 |
90 | positive regulation of hemostasis (GO:1900048) | 2.97249333 |
91 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.97188839 |
92 | negative regulation of cell killing (GO:0031342) | 2.97188839 |
93 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.95920182 |
94 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 2.90878661 |
95 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.90424665 |
96 | negative regulation of B cell activation (GO:0050869) | 2.89451823 |
97 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.89138273 |
98 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.88851247 |
99 | dendritic cell migration (GO:0036336) | 2.88774405 |
100 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.88413320 |
101 | lymphocyte mediated immunity (GO:0002449) | 2.88017390 |
102 | cytokine secretion (GO:0050663) | 2.86786589 |
103 | T cell selection (GO:0045058) | 2.86534226 |
104 | response to interleukin-15 (GO:0070672) | 2.86063774 |
105 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.85634270 |
106 | natural killer cell differentiation (GO:0001779) | 2.83595840 |
107 | positive regulation of coagulation (GO:0050820) | 2.81874371 |
108 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.80390530 |
109 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.80335196 |
110 | negative regulation of innate immune response (GO:0045824) | 2.78768146 |
111 | regulation of immunoglobulin secretion (GO:0051023) | 2.77194327 |
112 | germinal center formation (GO:0002467) | 2.76485113 |
113 | regulation of cellular extravasation (GO:0002691) | 2.76285220 |
114 | cellular response to interleukin-15 (GO:0071350) | 2.75947735 |
115 | positive regulation of protein homooligomerization (GO:0032464) | 2.75775783 |
116 | positive regulation of pseudopodium assembly (GO:0031274) | 2.75716245 |
117 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.75586920 |
118 | definitive hemopoiesis (GO:0060216) | 2.67472757 |
119 | low-density lipoprotein particle remodeling (GO:0034374) | 2.66175800 |
120 | response to peptidoglycan (GO:0032494) | 2.63931370 |
121 | complement activation, alternative pathway (GO:0006957) | 2.62875241 |
122 | Golgi transport vesicle coating (GO:0048200) | 2.60949258 |
123 | COPI coating of Golgi vesicle (GO:0048205) | 2.60949258 |
124 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.59676918 |
125 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.58203610 |
126 | positive regulation of granulocyte differentiation (GO:0030854) | 2.56854506 |
127 | regulation of superoxide anion generation (GO:0032928) | 2.56758090 |
128 | negative regulation of protein activation cascade (GO:2000258) | 2.55634198 |
129 | type I interferon signaling pathway (GO:0060337) | 2.55193279 |
130 | cellular response to type I interferon (GO:0071357) | 2.55193279 |
131 | cholesterol efflux (GO:0033344) | 2.53961569 |
132 | regulation of humoral immune response (GO:0002920) | 2.51094623 |
133 | response to type I interferon (GO:0034340) | 2.50007692 |
134 | fibrinolysis (GO:0042730) | 2.47676252 |
135 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.46489894 |
136 | acute-phase response (GO:0006953) | 2.42398193 |
137 | response to laminar fluid shear stress (GO:0034616) | 2.42295583 |
138 | cellular response to ethanol (GO:0071361) | 2.40874554 |
139 | nuclear pore complex assembly (GO:0051292) | 2.37320077 |
140 | COPII vesicle coating (GO:0048208) | 2.35699593 |
141 | regulation of gamma-delta T cell activation (GO:0046643) | 2.35125988 |
142 | plasma lipoprotein particle organization (GO:0071827) | 2.34897068 |
143 | detection of molecule of bacterial origin (GO:0032490) | 2.33978525 |
144 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.33659349 |
145 | blood coagulation, intrinsic pathway (GO:0007597) | 2.32958499 |
146 | positive regulation of interferon-alpha production (GO:0032727) | 2.27444894 |
147 | regulation of histone H3-K27 methylation (GO:0061085) | 2.25945647 |
148 | protein-lipid complex subunit organization (GO:0071825) | 2.24065288 |
149 | negative regulation of complement activation (GO:0045916) | 2.23083885 |
150 | regulation of interferon-alpha production (GO:0032647) | 2.22090450 |
151 | cell adhesion mediated by integrin (GO:0033627) | 2.21316533 |
152 | skin morphogenesis (GO:0043589) | 2.21071514 |
153 | regulation of cholesterol esterification (GO:0010872) | 2.20059486 |
154 | nuclear pore organization (GO:0006999) | 2.19783647 |
155 | low-density lipoprotein particle clearance (GO:0034383) | 2.19627453 |
156 | negative regulation of humoral immune response (GO:0002921) | 2.19386216 |
157 | response to thyroid hormone (GO:0097066) | 2.18961253 |
158 | regulation of extracellular matrix organization (GO:1903053) | 2.17292245 |
159 | detection of other organism (GO:0098543) | 2.16396875 |
160 | regulation of cholesterol homeostasis (GO:2000188) | 2.16027842 |
161 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.14944127 |
162 | negative regulation of interleukin-17 production (GO:0032700) | 2.14639607 |
163 | regulation of activation of Janus kinase activity (GO:0010533) | 2.14106327 |
164 | oligosaccharide catabolic process (GO:0009313) | 2.14027380 |
165 | negative regulation of interleukin-12 production (GO:0032695) | 2.13925939 |
166 | positive regulation of tolerance induction (GO:0002645) | 2.13793345 |
167 | cellular response to virus (GO:0098586) | 2.12292966 |
168 | positive regulation of phagocytosis (GO:0050766) | 2.11875912 |
169 | cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) | 2.11413268 |
170 | progesterone metabolic process (GO:0042448) | 2.10454205 |
171 | NIK/NF-kappaB signaling (GO:0038061) | 10.5537382 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.32635146 |
2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.94251490 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.22568917 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.08463034 |
5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.80965414 |
6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.80956854 |
7 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.69811302 |
8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.59660982 |
9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.53617911 |
10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.35496216 |
11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.19277383 |
12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.09584688 |
13 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.08819961 |
14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.74050822 |
15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.73586590 |
16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.61840042 |
17 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.59783507 |
18 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.58866881 |
19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.52249175 |
20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.50586468 |
21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.50427297 |
22 | GATA1_22025678_ChIP-Seq_K562_Human | 2.47081127 |
23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.43830787 |
24 | MAF_26560356_Chip-Seq_TH1_Human | 2.34020714 |
25 | MYB_26560356_Chip-Seq_TH2_Human | 2.32364610 |
26 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.10714751 |
27 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.10552507 |
28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.04788355 |
29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.98430969 |
30 | * MYB_26560356_Chip-Seq_TH1_Human | 1.92118709 |
31 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.85392723 |
32 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.84617287 |
33 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.83219749 |
34 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.82728149 |
35 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.75963656 |
36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.74761515 |
37 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.73468235 |
38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.71618142 |
39 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.69533200 |
40 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.68220872 |
41 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.63910645 |
42 | * MYC_22102868_ChIP-Seq_BL_Human | 1.62806854 |
43 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.60013579 |
44 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.59616323 |
45 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.58055813 |
46 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.55637408 |
47 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.53679986 |
48 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.52581846 |
49 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.50887146 |
50 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.44604025 |
51 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.44227308 |
52 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41369588 |
53 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.40350982 |
54 | UTX_26944678_Chip-Seq_JUKART_Human | 1.40339783 |
55 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.39000232 |
56 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.38059902 |
57 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.34267955 |
58 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.33920214 |
59 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.30422278 |
60 | MAF_26560356_Chip-Seq_TH2_Human | 1.30311017 |
61 | SPI1_23127762_ChIP-Seq_K562_Human | 1.29405248 |
62 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.28631574 |
63 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.28367739 |
64 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.27610893 |
65 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27062321 |
66 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.26854668 |
67 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.25771178 |
68 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25401417 |
69 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.22157825 |
70 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.20959756 |
71 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.20478784 |
72 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.20326926 |
73 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.19170996 |
74 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17628336 |
75 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.17452461 |
76 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.17147356 |
77 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.16723762 |
78 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.16537440 |
79 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.16537440 |
80 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.15149397 |
81 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15040719 |
82 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.13630202 |
83 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.10961938 |
84 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.09167650 |
85 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08845311 |
86 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.06144230 |
87 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.03330580 |
88 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.02705279 |
89 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.02639976 |
90 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02337029 |
91 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.02103747 |
92 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01108002 |
93 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.99452471 |
94 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99255522 |
95 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.98107421 |
96 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.96128642 |
97 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.93457379 |
98 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.93064763 |
99 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.92435025 |
100 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.91225764 |
101 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90989432 |
102 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.90908852 |
103 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.90857130 |
104 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.90446510 |
105 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.90337433 |
106 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.89944597 |
107 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.88972534 |
108 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.88737644 |
109 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.88190025 |
110 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86216115 |
111 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.86130182 |
112 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.86116096 |
113 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.85193829 |
114 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84783338 |
115 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84686227 |
116 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.83492103 |
117 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.82768130 |
118 | GATA1_19941826_ChIP-Seq_K562_Human | 0.82682203 |
119 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.81810224 |
120 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.81027179 |
121 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.78538170 |
122 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.78175506 |
123 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.78151222 |
124 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76559236 |
125 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.74100675 |
126 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.74090404 |
127 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.72423504 |
128 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.71946843 |
129 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.71716104 |
130 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.71528284 |
131 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71405551 |
132 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.70829499 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002138_abnormal_hepatobiliary_system | 5.57965308 |
2 | MP0002254_reproductive_system_inflammat | 4.90762041 |
3 | MP0001835_abnormal_antigen_presentation | 4.22039224 |
4 | MP0002166_altered_tumor_susceptibility | 3.98422276 |
5 | MP0002009_preneoplasia | 3.98325284 |
6 | MP0000685_abnormal_immune_system | 3.69536660 |
7 | MP0004510_myositis | 3.49580678 |
8 | MP0002006_tumorigenesis | 3.11978079 |
9 | MP0001348_abnormal_lacrimal_gland | 3.02901730 |
10 | MP0001790_abnormal_immune_system | 3.01980046 |
11 | MP0005387_immune_system_phenotype | 3.01980046 |
12 | MP0001800_abnormal_humoral_immune | 2.65007668 |
13 | MP0002877_abnormal_melanocyte_morpholog | 2.58738192 |
14 | MP0002148_abnormal_hypersensitivity_rea | 2.52885166 |
15 | MP0003436_decreased_susceptibility_to | 2.48733811 |
16 | MP0002139_abnormal_hepatobiliary_system | 2.48629181 |
17 | MP0005000_abnormal_immune_tolerance | 2.41093457 |
18 | MP0002452_abnormal_antigen_presenting | 2.39090680 |
19 | MP0005671_abnormal_response_to | 2.32296980 |
20 | MP0002163_abnormal_gland_morphology | 2.25714106 |
21 | MP0001873_stomach_inflammation | 2.25630955 |
22 | MP0005310_abnormal_salivary_gland | 2.23423592 |
23 | MP0002723_abnormal_immune_serum | 2.23079198 |
24 | MP0001819_abnormal_immune_cell | 2.11907009 |
25 | MP0002420_abnormal_adaptive_immunity | 2.11088338 |
26 | MP0009785_altered_susceptibility_to | 2.10621107 |
27 | MP0002419_abnormal_innate_immunity | 1.94348929 |
28 | MP0000569_abnormal_digit_pigmentation | 1.94293198 |
29 | MP0005025_abnormal_response_to | 1.86008867 |
30 | MP0006054_spinal_hemorrhage | 1.79869569 |
31 | MP0010352_gastrointestinal_tract_polyps | 1.79067708 |
32 | MP0001346_abnormal_lacrimal_gland | 1.78925997 |
33 | MP0005451_abnormal_body_composition | 1.77802930 |
34 | MP0004947_skin_inflammation | 1.75508964 |
35 | MP0000716_abnormal_immune_system | 1.74897922 |
36 | MP0002398_abnormal_bone_marrow | 1.74420010 |
37 | MP0002277_abnormal_respiratory_mucosa | 1.70938590 |
38 | MP0003300_gastrointestinal_ulcer | 1.60418891 |
39 | MP0001853_heart_inflammation | 1.57680431 |
40 | MP0002396_abnormal_hematopoietic_system | 1.56209857 |
41 | MP0003806_abnormal_nucleotide_metabolis | 1.55841335 |
42 | MP0003303_peritoneal_inflammation | 1.55094478 |
43 | MP0003763_abnormal_thymus_physiology | 1.54149279 |
44 | MP0001915_intracranial_hemorrhage | 1.51343538 |
45 | MP0009697_abnormal_copulation | 1.51157579 |
46 | MP0003656_abnormal_erythrocyte_physiolo | 1.45717069 |
47 | MP0002405_respiratory_system_inflammati | 1.44927247 |
48 | MP0005365_abnormal_bile_salt | 1.42514359 |
49 | MP0010155_abnormal_intestine_physiology | 1.40678594 |
50 | MP0002429_abnormal_blood_cell | 1.39177960 |
51 | MP0003453_abnormal_keratinocyte_physiol | 1.36541853 |
52 | MP0005409_darkened_coat_color | 1.35564276 |
53 | MP0003091_abnormal_cell_migration | 1.33232902 |
54 | MP0000465_gastrointestinal_hemorrhage | 1.31445781 |
55 | MP0005408_hypopigmentation | 1.30481987 |
56 | MP0001851_eye_inflammation | 1.29901769 |
57 | MP0008260_abnormal_autophagy | 1.29184084 |
58 | MP0000689_abnormal_spleen_morphology | 1.28261480 |
59 | MP0002132_abnormal_respiratory_system | 1.25336254 |
60 | MP0003252_abnormal_bile_duct | 1.24812930 |
61 | MP0002722_abnormal_immune_system | 1.24643327 |
62 | MP0005360_urolithiasis | 1.23085806 |
63 | MP0001845_abnormal_inflammatory_respons | 1.21763312 |
64 | MP0005076_abnormal_cell_differentiation | 1.21710242 |
65 | MP0004264_abnormal_extraembryonic_tissu | 1.18888255 |
66 | MP0010368_abnormal_lymphatic_system | 1.17828775 |
67 | MP0003448_altered_tumor_morphology | 1.16952660 |
68 | MP0001879_abnormal_lymphatic_vessel | 1.16809673 |
69 | MP0005164_abnormal_response_to | 1.16640303 |
70 | MP0001666_abnormal_nutrient_absorption | 1.13466522 |
71 | MP0002933_joint_inflammation | 1.08941904 |
72 | MP0005085_abnormal_gallbladder_physiolo | 1.08444888 |
73 | MP0001533_abnormal_skeleton_physiology | 1.07384857 |
74 | MP0005379_endocrine/exocrine_gland_phen | 1.06515003 |
75 | MP0008875_abnormal_xenobiotic_pharmacok | 1.05988996 |
76 | MP0008057_abnormal_DNA_replication | 1.05251131 |
77 | MP0003705_abnormal_hypodermis_morpholog | 1.02903338 |
78 | MP0000703_abnormal_thymus_morphology | 1.02547146 |
79 | MP0008469_abnormal_protein_level | 1.00380111 |
80 | MP0003221_abnormal_cardiomyocyte_apopto | 1.00136204 |
81 | MP0001545_abnormal_hematopoietic_system | 0.99838591 |
82 | MP0005397_hematopoietic_system_phenotyp | 0.99838591 |
83 | MP0004883_abnormal_blood_vessel | 0.99051033 |
84 | MP0005058_abnormal_lysosome_morphology | 0.97090977 |
85 | MP0004808_abnormal_hematopoietic_stem | 0.96687106 |
86 | MP0005464_abnormal_platelet_physiology | 0.96453133 |
87 | MP0001243_abnormal_dermal_layer | 0.95551623 |
88 | MP0003868_abnormal_feces_composition | 0.94884692 |
89 | MP0010234_abnormal_vibrissa_follicle | 0.94771852 |
90 | MP0005023_abnormal_wound_healing | 0.94499834 |
91 | MP0003566_abnormal_cell_adhesion | 0.90644542 |
92 | MP0003724_increased_susceptibility_to | 0.90380296 |
93 | MP0000604_amyloidosis | 0.89252153 |
94 | MP0009333_abnormal_splenocyte_physiolog | 0.88042108 |
95 | MP0010329_abnormal_lipoprotein_level | 0.87675266 |
96 | MP0009763_increased_sensitivity_to | 0.87650405 |
97 | MP0009764_decreased_sensitivity_to | 0.87019360 |
98 | MP0000598_abnormal_liver_morphology | 0.86881442 |
99 | MP0002998_abnormal_bone_remodeling | 0.85923796 |
100 | MP0006082_CNS_inflammation | 0.85578015 |
101 | MP0005621_abnormal_cell_physiology | 0.84861111 |
102 | MP0005174_abnormal_tail_pigmentation | 0.82690756 |
103 | MP0003075_altered_response_to | 0.82235797 |
104 | MP0000858_altered_metastatic_potential | 0.80557660 |
105 | MP0000767_abnormal_smooth_muscle | 0.78577543 |
106 | MP0001881_abnormal_mammary_gland | 0.74615555 |
107 | MP0003943_abnormal_hepatobiliary_system | 0.74206886 |
108 | MP0000249_abnormal_blood_vessel | 0.72971426 |
109 | MP0009840_abnormal_foam_cell | 0.71584924 |
110 | MP0003195_calcinosis | 0.70724631 |
111 | MP0001730_embryonic_growth_arrest | 0.70380774 |
112 | MP0000627_abnormal_mammary_gland | 0.68765038 |
113 | MP0002136_abnormal_kidney_physiology | 0.68643354 |
114 | MP0000371_diluted_coat_color | 0.65917238 |
115 | MP0000733_abnormal_muscle_development | 0.64257591 |
116 | MP0003191_abnormal_cellular_cholesterol | 0.63249425 |
117 | MP0001216_abnormal_epidermal_layer | 0.62449368 |
118 | MP0002019_abnormal_tumor_incidence | 0.58674890 |
119 | MP0003866_abnormal_defecation | 0.57787241 |
120 | MP0001958_emphysema | 0.57108692 |
121 | MP0009278_abnormal_bone_marrow | 0.53775024 |
122 | MP0002295_abnormal_pulmonary_circulatio | 0.52738059 |
123 | MP0003183_abnormal_peptide_metabolism | 0.52531415 |
124 | MP0008007_abnormal_cellular_replicative | 0.52432632 |
125 | MP0001191_abnormal_skin_condition | 0.51942339 |
126 | MP0010307_abnormal_tumor_latency | 0.51470552 |
127 | MP0003828_pulmonary_edema | 0.51422013 |
128 | MP0001765_abnormal_ion_homeostasis | 0.50364304 |
129 | MP0004185_abnormal_adipocyte_glucose | 0.49167153 |
130 | MP0003045_fibrosis | 0.47330541 |
131 | MP0000609_abnormal_liver_physiology | 0.47256688 |
132 | MP0000490_abnormal_crypts_of | 0.46282078 |
133 | MP0000613_abnormal_salivary_gland | 0.45535048 |
134 | MP0003172_abnormal_lysosome_physiology | 0.45136946 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 5.59030442 |
2 | Fatigue (HP:0012378) | 5.38730624 |
3 | Recurrent viral infections (HP:0004429) | 5.27432365 |
4 | Recurrent fungal infections (HP:0002841) | 4.83383361 |
5 | Chronic otitis media (HP:0000389) | 4.75903349 |
6 | Recurrent bacterial skin infections (HP:0005406) | 4.31871581 |
7 | Thrombocytosis (HP:0001894) | 4.19129307 |
8 | Eczematoid dermatitis (HP:0000976) | 4.18830044 |
9 | Increased IgE level (HP:0003212) | 4.14100290 |
10 | Agammaglobulinemia (HP:0004432) | 4.12124927 |
11 | Recurrent abscess formation (HP:0002722) | 4.00759856 |
12 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.99008905 |
13 | Gastrointestinal infarctions (HP:0005244) | 3.86263304 |
14 | Polycythemia (HP:0001901) | 3.85894443 |
15 | Colitis (HP:0002583) | 3.85025878 |
16 | Myocardial infarction (HP:0001658) | 3.83351988 |
17 | Nasal polyposis (HP:0100582) | 3.80424653 |
18 | Abnormality of the common coagulation pathway (HP:0010990) | 3.78831751 |
19 | Hematochezia (HP:0002573) | 3.72612203 |
20 | Optic neuritis (HP:0100653) | 3.71428931 |
21 | Retrobulbar optic neuritis (HP:0100654) | 3.71428931 |
22 | Mediastinal lymphadenopathy (HP:0100721) | 3.68580544 |
23 | Peritonitis (HP:0002586) | 3.65500396 |
24 | Myositis (HP:0100614) | 3.63349721 |
25 | Pulmonary infiltrates (HP:0002113) | 3.56732228 |
26 | Osteolytic defects of the hand bones (HP:0009699) | 3.50591207 |
27 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.50591207 |
28 | Orchitis (HP:0100796) | 3.50085378 |
29 | Arterial thrombosis (HP:0004420) | 3.46559224 |
30 | Recurrent bronchitis (HP:0002837) | 3.45808041 |
31 | Vasculitis (HP:0002633) | 3.41940727 |
32 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.39850499 |
33 | Abnormality of the nasal mucosa (HP:0000433) | 3.39514986 |
34 | Flat acetabular roof (HP:0003180) | 3.31136492 |
35 | Eosinophilia (HP:0001880) | 3.29661371 |
36 | Cortical dysplasia (HP:0002539) | 3.28676663 |
37 | Recurrent skin infections (HP:0001581) | 3.28659723 |
38 | Inflammation of the large intestine (HP:0002037) | 3.28215085 |
39 | Abnormality of the fingertips (HP:0001211) | 3.19277412 |
40 | Prolonged partial thromboplastin time (HP:0003645) | 3.15853285 |
41 | Recurrent cutaneous fungal infections (HP:0011370) | 3.10450496 |
42 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.10450496 |
43 | Gastrointestinal inflammation (HP:0004386) | 3.09886350 |
44 | Joint hemorrhage (HP:0005261) | 3.06048219 |
45 | Periodontitis (HP:0000704) | 3.05670791 |
46 | Panhypogammaglobulinemia (HP:0003139) | 3.05304588 |
47 | Complement deficiency (HP:0004431) | 3.04229311 |
48 | Hypergammaglobulinemia (HP:0010702) | 3.01069693 |
49 | Cellulitis (HP:0100658) | 2.98040005 |
50 | Autoimmune thrombocytopenia (HP:0001973) | 2.97877074 |
51 | Leukocytosis (HP:0001974) | 2.96519106 |
52 | Granulocytopenia (HP:0001913) | 2.96017438 |
53 | Abnormality of macrophages (HP:0004311) | 2.93705965 |
54 | Hemorrhage of the eye (HP:0011885) | 2.91066462 |
55 | Esophageal varix (HP:0002040) | 2.89576924 |
56 | Cerebral hemorrhage (HP:0001342) | 2.88741197 |
57 | Increased IgM level (HP:0003496) | 2.81702728 |
58 | Gingival bleeding (HP:0000225) | 2.80555597 |
59 | Abnormality of T cell number (HP:0011839) | 2.79041991 |
60 | Papilloma (HP:0012740) | 2.75508557 |
61 | Verrucae (HP:0200043) | 2.75508557 |
62 | Hypobetalipoproteinemia (HP:0003563) | 2.72832323 |
63 | Gastrointestinal stroma tumor (HP:0100723) | 2.72042145 |
64 | Abnormality of complement system (HP:0005339) | 2.71525171 |
65 | Anhidrosis (HP:0000970) | 2.71474939 |
66 | Emphysema (HP:0002097) | 2.68214563 |
67 | Interstitial pulmonary disease (HP:0006530) | 2.67901695 |
68 | Meningitis (HP:0001287) | 2.67115029 |
69 | Systemic lupus erythematosus (HP:0002725) | 2.65865462 |
70 | Chest pain (HP:0100749) | 2.60711679 |
71 | Spontaneous hematomas (HP:0007420) | 2.57852734 |
72 | Abnormality of eosinophils (HP:0001879) | 2.57127622 |
73 | Persistence of primary teeth (HP:0006335) | 2.51544556 |
74 | Chronic sinusitis (HP:0011109) | 2.51288292 |
75 | Purpura (HP:0000979) | 2.51268947 |
76 | Abnormality of T cell physiology (HP:0011840) | 2.50497730 |
77 | Abnormality of the lumbar spine (HP:0100712) | 2.49239124 |
78 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.46252595 |
79 | Acute myeloid leukemia (HP:0004808) | 2.43469699 |
80 | Abnormal foot bone ossification (HP:0010675) | 2.41244854 |
81 | Abnormality of T cells (HP:0002843) | 2.39272265 |
82 | Glomerulonephritis (HP:0000099) | 2.39057886 |
83 | Dysostosis multiplex (HP:0000943) | 2.34470799 |
84 | Lymphopenia (HP:0001888) | 2.33244672 |
85 | Pustule (HP:0200039) | 2.31455871 |
86 | Menorrhagia (HP:0000132) | 2.31222961 |
87 | Keratoconjunctivitis sicca (HP:0001097) | 2.29152629 |
88 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.27522264 |
89 | T lymphocytopenia (HP:0005403) | 2.27468306 |
90 | Amaurosis fugax (HP:0100576) | 2.25639065 |
91 | Gingivitis (HP:0000230) | 2.25186315 |
92 | Hemoptysis (HP:0002105) | 2.23221850 |
93 | Thyroiditis (HP:0100646) | 2.22472338 |
94 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.21837468 |
95 | Encephalitis (HP:0002383) | 2.20719088 |
96 | Chronic diarrhea (HP:0002028) | 2.19515086 |
97 | Epistaxis (HP:0000421) | 2.18917994 |
98 | Osteomyelitis (HP:0002754) | 2.18324975 |
99 | Abnormality of carpal bone ossification (HP:0006257) | 2.16830710 |
100 | Broad palm (HP:0001169) | 2.16713228 |
101 | Keratoconjunctivitis (HP:0001096) | 2.15629199 |
102 | Mucopolysacchariduria (HP:0008155) | 2.15283985 |
103 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.15283985 |
104 | Pulmonary embolism (HP:0002204) | 2.14968045 |
105 | Autoimmune hemolytic anemia (HP:0001890) | 2.14846892 |
106 | Ankyloglossia (HP:0010296) | 2.13688127 |
107 | Subacute progressive viral hepatitis (HP:0006572) | 2.13683956 |
108 | Tetraparesis (HP:0002273) | 2.11568233 |
109 | Vertebral compression fractures (HP:0002953) | 2.11107345 |
110 | Mitral stenosis (HP:0001718) | 2.10930403 |
111 | Prolonged bleeding time (HP:0003010) | 2.10755397 |
112 | Abnormality of the peritoneum (HP:0002585) | 2.07783751 |
113 | Porencephaly (HP:0002132) | 2.05920041 |
114 | IgA deficiency (HP:0002720) | 2.05713360 |
115 | Small epiphyses (HP:0010585) | 2.04533302 |
116 | Skin ulcer (HP:0200042) | 2.04454478 |
117 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.04250359 |
118 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.04250359 |
119 | Abnormality of glycolipid metabolism (HP:0010969) | 2.04250359 |
120 | Abnormal tarsal ossification (HP:0008369) | 2.03785346 |
121 | Coarse hair (HP:0002208) | 2.03234552 |
122 | Portal hypertension (HP:0001409) | 2.01048328 |
123 | Hypercholesterolemia (HP:0003124) | 2.00747525 |
124 | Cupped ribs (HP:0000887) | 2.00396337 |
125 | Asymmetry of the thorax (HP:0001555) | 2.00143591 |
126 | Abnormality of the periventricular white matter (HP:0002518) | 1.99548985 |
127 | Thickened calvaria (HP:0002684) | 1.98731295 |
128 | Conjugated hyperbilirubinemia (HP:0002908) | 1.98662044 |
129 | Pulmonary artery stenosis (HP:0004415) | 1.97709373 |
130 | Gangrene (HP:0100758) | 1.96655895 |
131 | Recurrent lower respiratory tract infections (HP:0002783) | 1.95609286 |
132 | Viral hepatitis (HP:0006562) | 1.94685833 |
133 | Abnormality of the intrinsic pathway (HP:0010989) | 1.93760496 |
134 | Abnormality of oral frenula (HP:0000190) | 1.92778308 |
135 | Stomach cancer (HP:0012126) | 1.91616251 |
136 | Amyloidosis (HP:0011034) | 1.91373249 |
137 | B lymphocytopenia (HP:0010976) | 1.91324832 |
138 | Abnormality of B cell number (HP:0010975) | 1.91324832 |
139 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.90171225 |
140 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.90171225 |
141 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.90171225 |
142 | Recurrent pneumonia (HP:0006532) | 1.89236212 |
143 | Joint swelling (HP:0001386) | 1.86318178 |
144 | Exertional dyspnea (HP:0002875) | 1.85857174 |
145 | Bronchitis (HP:0012387) | 1.85776240 |
146 | Vascular calcification (HP:0004934) | 1.85736567 |
147 | Thrombophlebitis (HP:0004418) | 1.85375186 |
148 | Abnormality of the acetabulum (HP:0003170) | 1.83410387 |
149 | Papillary thyroid carcinoma (HP:0002895) | 1.82369115 |
150 | Flared iliac wings (HP:0002869) | 1.81743121 |
151 | Scanning speech (HP:0002168) | 1.80047713 |
152 | Glomerulopathy (HP:0100820) | 1.78843074 |
153 | Vacuolated lymphocytes (HP:0001922) | 1.72830807 |
154 | Abnormal platelet volume (HP:0011876) | 1.72805930 |
155 | 11 pairs of ribs (HP:0000878) | 1.71110357 |
156 | Xanthomatosis (HP:0000991) | 1.70885646 |
157 | Abnormal ossification of hand bones (HP:0005921) | 1.70442932 |
158 | Spinal cord lesions (HP:0100561) | 1.70170928 |
159 | Syringomyelia (HP:0003396) | 1.70170928 |
160 | Broad alveolar ridges (HP:0000187) | 1.69181475 |
161 | Arterial tortuosity (HP:0005116) | 1.67990940 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K14 | 5.85971054 |
2 | MAP3K13 | 4.18082860 |
3 | TYK2 | 3.90557787 |
4 | IKBKB | 3.76939761 |
5 | JAK3 | 3.48215847 |
6 | CHUK | 2.98239299 |
7 | JAK1 | 2.78528292 |
8 | TBK1 | 2.77085317 |
9 | EPHB1 | 2.58646187 |
10 | FLT3 | 2.51474434 |
11 | PRPF4B | 2.41625280 |
12 | IKBKE | 2.36177030 |
13 | LATS1 | 2.21159409 |
14 | MAP4K1 | 2.17297940 |
15 | KIT | 2.08068822 |
16 | MST1R | 2.06851709 |
17 | CSF1R | 1.98067188 |
18 | IRAK4 | 1.86298605 |
19 | PRKAA2 | 1.84686770 |
20 | FGFR4 | 1.82655663 |
21 | EPHA3 | 1.68610554 |
22 | PKN1 | 1.66425484 |
23 | NEK9 | 1.59234616 |
24 | PDGFRA | 1.55619880 |
25 | FGFR3 | 1.49294446 |
26 | EPHA2 | 1.46960132 |
27 | BRD4 | 1.45871298 |
28 | MAP3K2 | 1.44114722 |
29 | ICK | 1.43269890 |
30 | LRRK2 | 1.37016770 |
31 | PTK6 | 1.36589340 |
32 | MATK | 1.31125471 |
33 | MAP3K10 | 1.27696639 |
34 | MAP3K6 | 1.26124062 |
35 | BTK | 1.18382214 |
36 | YES1 | 1.18089662 |
37 | SYK | 1.16671178 |
38 | GRK6 | 1.16622265 |
39 | TTN | 1.14066599 |
40 | NLK | 1.13367214 |
41 | JAK2 | 1.11245543 |
42 | RPS6KA4 | 1.10178435 |
43 | SIK3 | 1.08035808 |
44 | SMG1 | 1.04202394 |
45 | CDK4 | 1.03721863 |
46 | ZAP70 | 1.02832094 |
47 | KSR2 | 1.00553207 |
48 | STK10 | 0.99503557 |
49 | PIM1 | 0.99336424 |
50 | CAMKK2 | 0.96909473 |
51 | RIPK4 | 0.95887871 |
52 | LCK | 0.95817181 |
53 | BLK | 0.94886958 |
54 | TAOK3 | 0.94778027 |
55 | IRAK1 | 0.92262408 |
56 | MET | 0.90569837 |
57 | MAPKAPK2 | 0.89141188 |
58 | MAP3K1 | 0.88896689 |
59 | MAPK11 | 0.83723730 |
60 | TRIB3 | 0.82854210 |
61 | TEC | 0.81969445 |
62 | CSK | 0.81295837 |
63 | TGFBR1 | 0.80268697 |
64 | RET | 0.80123206 |
65 | EIF2AK3 | 0.78157780 |
66 | STK4 | 0.77318014 |
67 | RPS6KB2 | 0.76202756 |
68 | ITK | 0.73587211 |
69 | TAOK2 | 0.73449835 |
70 | PRKCQ | 0.72542648 |
71 | EIF2AK1 | 0.69717976 |
72 | BMX | 0.69368594 |
73 | TRPM7 | 0.68647733 |
74 | CLK1 | 0.68551147 |
75 | CDK12 | 0.66555197 |
76 | SCYL2 | 0.66475619 |
77 | MST4 | 0.66470486 |
78 | RPS6KA5 | 0.65010953 |
79 | STK3 | 0.64276167 |
80 | HCK | 0.63338642 |
81 | RIPK1 | 0.62958099 |
82 | ERN1 | 0.61554481 |
83 | LATS2 | 0.60875058 |
84 | CDK7 | 0.59659333 |
85 | MAP2K3 | 0.58758644 |
86 | BRSK2 | 0.58566916 |
87 | PAK4 | 0.58073184 |
88 | HIPK2 | 0.56196253 |
89 | IRAK2 | 0.55706291 |
90 | FES | 0.55563666 |
91 | WNK1 | 0.54537971 |
92 | IRAK3 | 0.54379712 |
93 | PDGFRB | 0.53513731 |
94 | SRPK1 | 0.50831200 |
95 | PASK | 0.50499858 |
96 | ERBB3 | 0.50423660 |
97 | STK24 | 0.49663698 |
98 | ABL1 | 0.49580190 |
99 | PIM2 | 0.49473198 |
100 | DYRK1B | 0.48886978 |
101 | TXK | 0.47953323 |
102 | NUAK1 | 0.47922743 |
103 | SGK1 | 0.47036143 |
104 | PBK | 0.46608792 |
105 | RPS6KA1 | 0.46446854 |
106 | MAP3K5 | 0.44810953 |
107 | RAF1 | 0.44322025 |
108 | BMPR2 | 0.44264856 |
109 | ACVR1B | 0.44087597 |
110 | FGR | 0.44039570 |
111 | MAP2K2 | 0.43901723 |
112 | SGK3 | 0.43659983 |
113 | MELK | 0.43513049 |
114 | FGFR1 | 0.43219929 |
115 | PRKCD | 0.42861356 |
116 | LYN | 0.42826001 |
117 | EIF2AK2 | 0.42599732 |
118 | KDR | 0.42459303 |
119 | GSK3A | 0.42296857 |
120 | MAP3K3 | 0.41539172 |
121 | AKT1 | 0.41054562 |
122 | MAP3K7 | 0.41013167 |
123 | CDK9 | 0.40689931 |
124 | CDK6 | 0.39657326 |
125 | MAP3K8 | 0.39207646 |
126 | EEF2K | 0.38662703 |
127 | EGFR | 0.38210346 |
128 | TESK2 | 0.36302066 |
129 | TGFBR2 | 0.34985093 |
130 | BCR | 0.32710547 |
131 | MOS | 0.31828595 |
132 | PRKCZ | 0.31315502 |
133 | PAK3 | 0.29721751 |
134 | DYRK3 | 0.29113928 |
135 | DMPK | 0.28486804 |
136 | FGFR2 | 0.27084340 |
137 | SIK1 | 0.26057437 |
138 | INSR | 0.25824917 |
139 | PKN2 | 0.25014911 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.92108611 |
2 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.90305768 |
3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.76074452 |
4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.75025094 |
5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.72921851 |
6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.69078270 |
7 | Allograft rejection_Homo sapiens_hsa05330 | 2.66920374 |
8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.65547019 |
9 | Toxoplasmosis_Homo sapiens_hsa05145 | 2.43725034 |
10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.41218508 |
11 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.40487479 |
12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.38673057 |
13 | Measles_Homo sapiens_hsa05162 | 2.37097543 |
14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.31356939 |
15 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.26388194 |
16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.21989359 |
17 | Apoptosis_Homo sapiens_hsa04210 | 2.19093390 |
18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.98371552 |
19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.87652198 |
20 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.86125681 |
21 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.84989170 |
22 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.82420395 |
23 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.78521744 |
24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.73916478 |
25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.73206840 |
26 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.62158297 |
27 | Shigellosis_Homo sapiens_hsa05131 | 1.55910757 |
28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.52897596 |
29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.51082563 |
30 | Legionellosis_Homo sapiens_hsa05134 | 1.48022552 |
31 | Influenza A_Homo sapiens_hsa05164 | 1.47501568 |
32 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.46984444 |
33 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.43779256 |
34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.42257068 |
35 | Tuberculosis_Homo sapiens_hsa05152 | 1.33204767 |
36 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.32342227 |
37 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.30142584 |
38 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.28479113 |
39 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.27177724 |
40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.23382773 |
41 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.21592617 |
42 | Pertussis_Homo sapiens_hsa05133 | 1.21399055 |
43 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.19033579 |
44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.16461503 |
45 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.11217979 |
46 | Malaria_Homo sapiens_hsa05144 | 1.10346373 |
47 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.10235841 |
48 | Hepatitis B_Homo sapiens_hsa05161 | 1.10026814 |
49 | Hepatitis C_Homo sapiens_hsa05160 | 1.09502254 |
50 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.08770970 |
51 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.08375369 |
52 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.08189187 |
53 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.07117874 |
54 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.02036669 |
55 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.01667436 |
56 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.00987933 |
57 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.99676181 |
58 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.99085663 |
59 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.98924359 |
60 | Thyroid cancer_Homo sapiens_hsa05216 | 0.96435798 |
61 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.92912110 |
62 | Salmonella infection_Homo sapiens_hsa05132 | 0.87869305 |
63 | HTLV-I infection_Homo sapiens_hsa05166 | 0.87308209 |
64 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.86795056 |
65 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.85123410 |
66 | Insulin resistance_Homo sapiens_hsa04931 | 0.84892773 |
67 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.82550413 |
68 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.80883350 |
69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.80730581 |
70 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.79098269 |
71 | Bladder cancer_Homo sapiens_hsa05219 | 0.78366843 |
72 | Platelet activation_Homo sapiens_hsa04611 | 0.77378714 |
73 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.75669381 |
74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.74917597 |
75 | Prion diseases_Homo sapiens_hsa05020 | 0.74465021 |
76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.74459683 |
77 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.74112963 |
78 | Endometrial cancer_Homo sapiens_hsa05213 | 0.67369988 |
79 | Asthma_Homo sapiens_hsa05310 | 0.65298193 |
80 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.65274663 |
81 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64851695 |
82 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.64160999 |
83 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.60210330 |
84 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.59938898 |
85 | Pathways in cancer_Homo sapiens_hsa05200 | 0.59614447 |
86 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.59311592 |
87 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.56967090 |
88 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.56240930 |
89 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55640170 |
90 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.55545546 |
91 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54090353 |
92 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.53718448 |
93 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.52728907 |
94 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51943044 |
95 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51191917 |
96 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50454975 |
97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50093127 |
98 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.49476799 |
99 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.49030186 |
100 | Focal adhesion_Homo sapiens_hsa04510 | 0.48619468 |
101 | Amoebiasis_Homo sapiens_hsa05146 | 0.48429866 |
102 | Prostate cancer_Homo sapiens_hsa05215 | 0.48046893 |
103 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48006122 |
104 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.47811022 |
105 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.47654757 |
106 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.47336401 |
107 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.46913107 |
108 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.46885484 |
109 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.41311770 |
110 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.40686079 |
111 | Endocytosis_Homo sapiens_hsa04144 | 0.40014069 |
112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.38811137 |
113 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.35862702 |
114 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.34282105 |
115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.33851674 |
116 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.31450324 |
117 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.30822368 |
118 | Adherens junction_Homo sapiens_hsa04520 | 0.30628307 |
119 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.29217971 |
120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.28976547 |
121 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.28776184 |
122 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.28177078 |
123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.27554129 |
124 | Lysosome_Homo sapiens_hsa04142 | 0.26326199 |
125 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.25642776 |
126 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.25630794 |
127 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.23452937 |
128 | Colorectal cancer_Homo sapiens_hsa05210 | 0.23415676 |
129 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.20420043 |
130 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.20194575 |
131 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.18619723 |